Acute leukemia patients treated with common therapy have increased risk for heart failure
Patients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) who are treated with anthracyclines are at a heightened risk of heart failure—most often within one year of exposure to the chemotherapy treatment, ...
Dec 17, 2019
0
3